log  
logo
a Journal of Postdoctoral Research and Postdoctoral Affairs.
logo
    ISSN : 2328-9791 Contact Us
left right
 
 
Resolvin D1 for Targeting Chronic Lung Inflammation and Infection in cystic fibrosis
     
 
Author(s) : Recchiuti A, Mari VC, Codagnone M, Cianci E, Lamolinara A, Iezzi M, Bragonzi A, Moretti P, Nespoli A, Arita M, Romano M
Address : University of Chieti-Pescara, Chieti, Italy; San Raffaele Scientific Institute, Milan, Italy; RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan 
Multiple Universities in collaboration
Info@Postdocjournal.Com

Background. Endogenous resolution mechanisms that promote return to homeostasis are defective in cystic fibrosis (CF) leaving inflammation unrestrained with consequent loss of respiratory function, disability, and premature death of patients. Resolvin (Rv) D1 is and endogenous pro-resolution mediator that has entered clinical trials for the treatment of inflammatory diseases. Therefore, its therapeutic potential in CF is of wide interest.

Hypothesis and Objectives. Overarching hypotheses tested in this project are that RvD1 represents a potent therapeutic candidate for limiting lung inflammation and enhancing resolution of P. aeruginosa infection in CF. Main objectives are to determine, in preclinical models of CF, if RvD1 a) dampens lung inflammation and damage, b) promotes resolution and clearance of bacterial infection

 
btm
 
Discussion Board
 
Comments
 
     
btm
 
 
 
top
 
 
 
btm
top
btm

 
submit_article Announcements
 
submit_article Submit Your Article
 
submit_article Post your Job
footer
 
 
home phone mail info@postdocjournal.com
 
twitter facebook social icon Social link You Tube sky
Click Here